A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease

Clinical trial NCT02280473 · COMPLETED

Trial details

NCT number: NCT02280473
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Eye Syndromes

Start date: 2014-11-13
Primary completion: 2015-03-16
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.